Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 13, 2023

Total Value ($000): $296,716 (100.0% shares, 0.0% debt)

Holdings (16)

— Imago Biosciences 36.6%

Value ($000) $108,524 Shares 3,018,737 Est. Cost $20.03 Unrealized —

REPL Replimune Group 30.8%

Value ($000) $91,441 Shares 3,361,806 Est. Cost $17.40 Unrealized +19.4%

NUVB Nuvation Bio 9.8%

Value ($000) $28,939 Shares 15,072,340 Est. Cost $11.18 Unrealized -81.9%

— Morphic Holding 5.4%

Value ($000) $15,989 Shares 597,723 Est. Cost $19.82 Unrealized —

— Alpine Immune Sciences 5.0%

Value ($000) $14,917 Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Cincor 2.6%

Value ($000) $7,854 Shares 560,985 Est. Cost $17.54 Unrealized —

— Kronos Bio 2.1%

Value ($000) $6,186 Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Ikena Oncology 2.0%

Value ($000) $5,983 Shares 2,249,123 Est. Cost $28.25 Unrealized —

— Paratek Pharmaceuticals 1.2%

Value ($000) $3,686 Shares 1,971,241 Est. Cost $34.18 Unrealized —

— Theseus Pharmaceuticals 1.2%

Value ($000) $3,543 Shares 711,479 Est. Cost $12.68 Unrealized —

SANA Sana Biotechnology, Inc. 1.1%

Value ($000) $3,333 Shares 843,750 Est. Cost $32.56 Unrealized -85.0%

IMUX Immunic Inc 0.8%

Value ($000) $2,503 Shares 1,788,160 Est. Cost $13.89 Unrealized -80.4%

— Spruce Biosciences 0.8%

Value ($000) $2,334 Shares 2,161,022 Est. Cost $24.31 Unrealized —

SYRS Syros Pharmaceuticals 0.3%

Value ($000) $902 Shares 251,270 Est. Cost $8.12 Unrealized -46.6%

— Jounce Therapeutics 0.1%

Value ($000) $306 Shares 275,513 Est. Cost $21.99 Unrealized —

— Senti Biosciences, Inc. 0.1%

Value ($000) $276 Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Imago Biosciences	3,018,737	$108,524	36.6%	$20.03	—	Common Stock	45250K107
REPL	Replimune Group	3,361,806	$91,441	30.8%	$17.40	+19.4%	Common Stock	76029N106
NUVB	Nuvation Bio	15,072,340	$28,939	9.8%	$11.18	-81.9%	Common Stock Class A	67080N101
—	Morphic Holding	597,723	$15,989	5.4%	$19.82	—	Common Stock	61775R105
—	Alpine Immune Sciences	2,029,580	$14,917	5.0%	$9.48	—	Common Stock	02083G100
—	Cincor	560,985	$7,854	2.6%	$17.54	—	Common Stock	17240Y109
—	Kronos Bio	3,818,283	$6,186	2.1%	$29.87	—	Common Stock	50107A104
—	Ikena Oncology	2,249,123	$5,983	2.0%	$28.25	—	Common Stock	45175G108
—	Paratek Pharmaceuticals	1,971,241	$3,686	1.2%	$34.18	—	Common Stock	699374302
—	Theseus Pharmaceuticals	711,479	$3,543	1.2%	$12.68	—	Common Stock	88369M101
SANA	Sana Biotechnology, Inc.	843,750	$3,333	1.1%	$32.56	-85.0%	Common Stock	799566104
IMUX	Immunic Inc	1,788,160	$2,503	0.8%	$13.89	-80.4%	Common Stock	4525EP101
—	Spruce Biosciences	2,161,022	$2,334	0.8%	$24.31	—	Common Stock	85209E109
SYRS	Syros Pharmaceuticals	251,270	$902	0.3%	$8.12	-46.6%	Common Stock	87184Q206
—	Jounce Therapeutics	275,513	$306	0.1%	$21.99	—	Common Stock	481116101
—	Senti Biosciences, Inc.	195,792	$276	0.1%	$1.97	—	Common Stock	81726A100